BOEHRINGER INGELHEIM PHARMACEUTICALS INC

Boehringer Ingelheim Pharmaceuticals Inc. specializes in the manufacturing of pharmaceutical preparations, focusing on the development and production of active pharmaceutical ingredients and finished dosage forms for clinical and commercial use. Their technical expertise includes GMP-compliant synthesis, formulation science, aseptic processing, and quality control systems aligned with FDA and international pharmacopeial standards. The company’s specialization in hematology-related therapeutics and specialty drug products positions them as a trusted supplier of complex, high-integrity pharmaceuticals for regulated medical applications. Their capability extends to end-to-end production workflows, from raw material handling through final packaging, ensuring batch consistency and regulatory adherence across the product lifecycle. The contractor has delivered pharmaceutical products under contract to the Department of Veterans Affairs, supplying essential medications for veteran healthcare programs, including specialty drugs used in chronic disease management and hematologic conditions. This relationship reflects a focus on fulfilling mission-critical drug supply needs within the federal healthcare delivery system, particularly for long-term and high-acuity patient populations. The primary NAICS code 325412 reflects core competency in pharmaceutical preparation manufacturing, encompassing the formulation, blending, and packaging of oral solids, injectables, and other dosage forms. The company operates within the specialty pharmaceuticals vertical, serving markets requiring stringent quality assurance, cold chain logistics, and controlled substance handling. Their market positioning is that of a precision manufacturer for government healthcare systems requiring reliable, compliant drug production. Boehringer Ingelheim Pharmaceuticals Inc. is a large-scale corporate entity structured as a 2L organization, headquartered in Ridgefield, Connecticut. While no federal certifications are listed, the company maintains full compliance with FDA regulations and cGMP standards, which are prerequisites for federal pharmaceutical procurement. Their geographic presence is centered in the U.S., with manufacturing and distribution infrastructure calibrated to meet federal supply chain requirements for secure, timely delivery of pharmaceuticals to government medical facilities.